e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NervGen Pharma Corp. - Common stock
(NQ:
NGEN
)
3.600
-0.270 (-6.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NervGen Pharma Corp. - Common stock
NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
March 12, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
March 04, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
NervGen Pharma to Participate at Upcoming Investor Conferences
February 18, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
February 12, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
February 11, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
February 09, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
January 20, 2026
From
NervGen Pharma Corp.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.